What is the diagnosis and treatment for Tinea capitis (Ringworm of the scalp)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tinea capitis, a fungal infection of the scalp, should be treated with oral antifungal medication, typically griseofulvin or terbinafine, for 6-8 weeks, as recommended by the British Association of Dermatologists' guidelines for the management of tinea capitis 2014 1. The choice of systemic therapy should be directed by the causative dermatophyte and/or local epidemiology, with terbinafine being more efficacious against Trichophyton species and griseofulvin more effective against Microsporum species 1.

  • The recommended dose of griseofulvin is 15-20 mg/kg/day for children weighing less than 50 kg and 1 g per day for children weighing more than 50 kg, for 6-8 weeks 1.
  • The recommended dose of terbinafine is 62.5 mg per day for children weighing less than 20 kg, 125 mg per day for children weighing 20-40 kg, and 250 mg per day for children weighing more than 40 kg, for 2-4 weeks 1. Treatment should be accompanied by antifungal shampoo containing ketoconazole or selenium sulfide used 2-3 times weekly to reduce spore shedding, and family members should be examined for infection and household items like combs, brushes, and bedding should be cleaned to prevent reinfection 1. Key considerations in the management of tinea capitis include:
  • Confirming the diagnosis through laboratory testing, such as microscopy and culture 1.
  • Allowing children to return to school once they have been commenced on appropriate systemic and adjuvant topical therapy and followed up until mycological clearance is documented 1.
  • Screening family members and close contacts for infection, particularly in cases due to T. tonsurans 1.

From the Research

Times Capitus

There are no research papers to assist in answering this question. The provided studies do not mention "Times capitus" and appear to be related to migraine treatment and diagnosis.

  • The studies discuss various treatments for migraine, including triptans, nonsteroidal anti-inflammatory drugs, and monoclonal antibodies 2, 3, 4.
  • Some studies examine the diagnostic utility of triptans in alleviating "sinus headache" and the use of neuroimaging in patients with migraine 5, 6.
  • However, none of the studies provide information on "Times capitus", suggesting that it may not be a recognized medical term or condition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.